Complex I deficiency in Parkinson's disease frontal cortex.
about
The role of oxidative stress in Parkinson's diseaseParkin-dependent degradation of the F-box protein Fbw7β promotes neuronal survival in response to oxidative stress by stabilizing Mcl-1PGC-1α, a potential therapeutic target for early intervention in Parkinson's diseaseAutophagy, mitochondria and oxidative stress: cross-talk and redox signallingmicroRNAs: Emerging Targets Regulating Oxidative Stress in the Models of Parkinson's DiseaseParkinson's Disease: The Mitochondria-Iron LinkThe Role of Autophagy, Mitophagy and Lysosomal Functions in Modulating Bioenergetics and Survival in the Context of Redox and Proteotoxic Damage: Implications for Neurodegenerative DiseasesOncostatic-Cytoprotective Effect of Melatonin and Other Bioactive Molecules: A Common Target in Mitochondrial RespirationElectron Transport Disturbances and Neurodegeneration: From Albert Szent-Györgyi's Concept (Szeged) till Novel Approaches to Boost Mitochondrial BioenergeticsOxidative stress and Parkinson's diseaseCerebral energy metabolism and the brain's functional network architecture: an integrative reviewOxidative stress and cerebral endothelial cells: regulation of the blood-brain-barrier and antioxidant based interventionsGenetically engineered mouse models of Parkinson's diseaseMetabolic disturbances in diseases with neurological involvementMitochondrial dysfunction and oxidative stress in Parkinson's diseaseBioenergetic adaptation in response to autophagy regulators during rotenone exposureIdentification of licopyranocoumarin and glycyrurol from herbal medicines as neuroprotective compounds for Parkinson's diseaseStem cell-based models and therapies for neurodegenerative diseasesDJ-1 knock-down impairs astrocyte mitochondrial function.Oxidative stress in skin fibroblasts cultures from patients with Parkinson's diseaseDecylubiquinone increases mitochondrial function in synaptosomesBrain mitochondria from DJ-1 knockout mice show increased respiration-dependent hydrogen peroxide consumption.Neuroproteomics as a promising tool in Parkinson's disease research.Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis.Lysosomal function in macromolecular homeostasis and bioenergetics in Parkinson's disease.The neurodegenerative mitochondriopathies.Tissue- and cell-type-specific manifestations of heteroplasmic mtDNA 3243A>G mutation in human induced pluripotent stem cell-derived disease model.Distinct effects of rotenone, 1-methyl-4-phenylpyridinium and 6-hydroxydopamine on cellular bioenergetics and cell death.PINK1 and Parkin to control mitochondria remodeling.Enhanced glutamate, IP3 and cAMP activity in the cerebral cortex of unilateral 6-hydroxydopamine induced Parkinson's rats: effect of 5-HT, GABA and bone marrow cell supplementation.Decreased glutamic acid decarboxylase mRNA expression in prefrontal cortex in Parkinson's disease.Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses.Mice lacking TR4 nuclear receptor develop mitochondrial myopathy with deficiency in complex I.N-terminal truncated UCH-L1 prevents Parkinson's disease associated damage.High-level inhibition of mitochondrial complexes III and IV is required to increase glutamate release from the nerve terminal.The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disordersMitochondrial Dysfunction and α-Synuclein Synaptic Pathology in Parkinson's Disease: Who's on First?Mask loss-of-function rescues mitochondrial impairment and muscle degeneration of Drosophila pink1 and parkin mutantsEarly Expression of Parkinson's Disease-Related Mitochondrial Abnormalities in PINK1 Knockout Rats.Mitochondrial dysfunction in genetic animal models of Parkinson's disease
P2860
Q24307946-91E5947D-DB9A-4C48-8F71-CB95D878CC7EQ24308897-DD5C5753-365F-4641-9747-800365CB06ABQ24597726-8E78D704-3B2E-4502-A784-32C3CD1A4507Q24608960-33A284CF-7ED9-4736-96CC-17B6512B497AQ26738440-B5BC7586-A958-49E4-B2A8-F03D0AB26587Q26746899-9E650F5F-2A43-41FD-8D75-DEA0579212FFQ26750137-B9C587C2-9365-4635-920A-139662E84A1BQ26766876-60FE9852-5E96-433E-8547-6F5D71F275BEQ26795417-50E62F6D-1BB8-43F6-BCEE-BAA386BB8667Q26798897-DBFFBD75-5268-4C58-BEC4-D6DB7B63C3BAQ26830365-27FA04DB-34F2-45FF-A2BA-59300F0A591BQ26851676-42461369-82F0-453F-AC20-5DEB4EA8D0F3Q26852964-26CE50B5-D575-4C63-B084-4FB8B660E336Q26999015-763ACEB1-D521-484D-9C12-695ACF52AC9FQ27014051-15AAFEA4-58DA-405D-8F5E-69A74B0A9B31Q28395471-BE31EC38-B173-4216-BF2D-7ED787C3CFCBQ28539943-ED65A35E-944F-4144-8331-C2CE8B70B694Q30451005-69917B61-0334-4443-BCCE-C9736526D45EQ30527966-6AA396B6-F7BC-41D3-9373-2025E2335B87Q33722784-FEF3B8FD-2975-495F-B88C-C97D93CBEF1FQ33726402-E6139D44-A7D6-47D7-827B-E657585EAD2FQ33737338-2FAC02CA-B01D-4356-AFF1-FCC87ECD6B94Q33821316-49A99B65-EA37-4D4A-BAAA-BA3CB918F95AQ33840243-E6525B12-8D38-47A3-B74C-62C7004DFBBBQ33843073-90F2AAD7-9C92-4B43-9684-A213A361889AQ33957065-4D6E7BF6-505A-4B80-AABC-51B511DBE58DQ34368460-73CCBF51-B967-49B1-B007-64BC9FA95A48Q34412601-3DCA032B-7D2B-4007-BD32-20F6ACB47CAFQ34462283-9B58B49A-C6D9-405E-A393-9E465DE9F47AQ34521827-A1F2286D-901A-40F2-A0A4-65F881E3E3F0Q35024422-3CB115BE-CCF2-4E3C-A19F-C6F62DD118BBQ35059951-8B48AF13-9339-449B-81A8-0C0126642F66Q35135711-BF96C9B0-E1FC-41FE-9AED-F7D8A039F65BQ35193829-2701CC6E-1224-4534-83B5-80A9C868B351Q35203821-E1E99B07-3B24-4893-BE21-082480690DA4Q35246024-DE782C15-4657-441F-B380-E77728E6D3E9Q35412397-9DAC7053-54F4-4AD4-8ADA-9CABDEA36033Q35585304-20ABCB71-2940-43A2-BAF3-38423A028EE9Q35642539-B03140A1-F0BF-4FDB-8166-C4EA406DB046Q35799109-704D18B6-19B9-4791-96E3-7EA1FBF7257C
P2860
Complex I deficiency in Parkinson's disease frontal cortex.
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Complex I deficiency in Parkinson's disease frontal cortex.
@ast
Complex I deficiency in Parkinson's disease frontal cortex.
@en
type
label
Complex I deficiency in Parkinson's disease frontal cortex.
@ast
Complex I deficiency in Parkinson's disease frontal cortex.
@en
prefLabel
Complex I deficiency in Parkinson's disease frontal cortex.
@ast
Complex I deficiency in Parkinson's disease frontal cortex.
@en
P2093
P2860
P1433
P1476
Complex I deficiency in Parkinson's disease frontal cortex.
@en
P2093
Janice K Parks
Russell H Swerdlow
W Davis Parker
P2860
P304
P356
10.1016/J.BRAINRES.2007.10.061
P407
P577
2007-11-01T00:00:00Z